Matthew Calistri
InvestorAssociate at Bain Capital · Managing Director at Bain Capital Life Sciences
Boston
Find your path to Matthew
810 people in our graph can introduce you to Matthew.
Sign up to see every warm intro you have to Matthew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Matthew. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Matthew Calistri is a Managing Director in the Portfolio Group of Bain Capital's Life Sciences business, which he joined in 2024. He previously spent four years at Cerevel Therapeutics, serving as VP of Investor Relations and VP of Corporate Strategy, and held investor relations roles at Sage and Biogen. Earlier in his career he worked in financial services at Gerson Lehrman Group, ITG, UBS, Bankers Trust, and E&Y, and he holds an MBA in finance from the University of Chicago Booth School of Business and a BS in accounting from Fordham University.
Invests in
Biotech
Experience
- Bain CapitalManaging Directorcurrent2024 — presentBoston, Massachusetts, United States
- Cerevel Therapeutics, LLCVice President - Investor Relations2020 — 2024Boston, Massachusetts, United States
- Cerevel Therapeutics, LLCVice President - Corporate Strategy and Investor Relations2021 — 2022Cambridge, Massachusetts, United States
- Sage TherapeuticsVice President - Investor Relations2019 — 2020Cambridge, USA
- BiogenVice President, Investor Relations2017 — 2019
- BiogenSenior Director - Investor Relations2015 — 2017Cambridge, MA
- BiogenSenior Director - Corporate Strategy2014 — 2015Cambridge, MA
- Investment Technology Group, Inc.Director - Boston Research Sales2011 — 2014
- Gerson Lehrman GroupManaging Director2001 — 2011
- UBS Investment BankInstitutional Sales1999 — 2001
- Ernst & YoungSenior Auditor1992 — 1995
Skills & more
+10 more
EquitiesAlternative InvestmentsFinanceAccount ManagementCompetitive AnalysisAsset ManagementDue DiligenceValuationInvestment BankingBusiness StrategyFrom Matthew's professional profile.
Colleagues at Bain Capital
Frequently asked questions
- Who is Matthew Calistri?
- Matthew Calistri is a Managing Director in the Portfolio Group of Bain Capital's Life Sciences business, which he joined in 2024. He previously spent four years at Cerevel Therapeutics, serving as VP of Investor Relations and VP of Corporate Strategy, and held investor relations roles at Sage and Biogen. Earlier in his career he worked in financial services at Gerson Lehrman Group, ITG, UBS, Bankers Trust, and E&Y, and he holds an MBA in finance from the University of Chicago Booth School of Business and a BS in accounting from Fordham University.
- Where does Matthew Calistri work?
- Matthew Calistri is Associate at Bain Capital and Managing Director at Bain Capital Life Sciences.
- What does Matthew Calistri invest in?
- Matthew Calistri invests in Biotech.
- Where did Matthew Calistri go to school?
- Matthew Calistri studied at The University of Chicago Booth School of Business (MBA, Finance); Fordham University (B.S., Accounting).
Same school
Also attended The University of Chicago Booth School of Business1,028
+ 1,022 more
Also attended Fordham University133
+ 127 more
Shared employers
Also worked at Sage Therapeutics14
+ 8 more
Also worked at Investment Technology Group, Inc.22
+ 16 more
Also worked at Gerson Lehrman Group114
+ 108 more
Also worked at UBS Investment Bank1,190
+ 1,184 more












































